The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Biz & Tech
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
Biz & Tech
Bio
  • Tech
  • Bio
  • Companies
Wed, December 8, 2021 | 17:54
Samsung, SK responding to Omicron COVID-19 variant
Samsung, SK responding to Omicron COVID-19 variant
Samsung Biologics, SK Bioscience, Celltrion, Seegene and other Korean biotech firms are responding to the latest COVID-19 variant called Omicron at a time when the new mutation could become an even greater concern than the Delta variant, according to companies Wednesday.
Baek Byung-yeul | 2021-12-01 17:05
Seegene test kits capable of detecting Omicron variant
Seegene test kits capable of detecting Omicron variant
With the global community facing the spread of the Omicron variant of COVID-19, Korean biotechnology company Seegene said Wednesday that its test kit is fully able to detect the new mutation.
Baek Byung-yeul | 2021-12-01 11:18
SCM Lifesciences appoints founder Song as CEO again
SCM Lifesciences appoints founder Song as CEO again
SCM Lifescience appointed its founder and chief strategy officer (CSO) Song Sun-uk as its new CEO, Monday.
Anna J. Park | 2021-11-15 15:40
Celltrion's COVID-19 antibody treatment wins EU drug agency's recommendation
Celltrion's COVID-19 antibody treatment wins EU drug agency's recommendation
The European Union's drug agency has recommended the approval of a COVID-19 antibody treatment by Celltrion, paving the way for its sales in the region, the South Korean pharmaceutical giant said Friday.
2021-11-12 14:28
  • EU watchdog backs two COVID antibody treatments
CJ remains upbeat over approval for Batavia acquisition
CJ remains upbeat over approval for Batavia acquisition
A few days after CJ Group - a mid-tier conglomerate in Korea focused on food and beverages - said it plans to invest up to 10 trillion won until 2023, its entertainment affiliate said it is about to enter the highly-lucrative biopharma CDMO business.
Kim Yoo-chul | 2021-11-09 15:17
 1 
Top 10 Stories
  • Foreign professor flees while being investigated for embezzling research funds
  • Korea's first Omicron patients face online wrath after private info leaked
  • Omicron variant feared to be spreading nationwide
  • Korea faces tougher dilemma over Olympics, peace initiative
  • Samsung replaces CEOs of 3 key business units
  • SK faces hurdles to building chip plant in US
  • Fed's earlier end to tapering prompts call for Korea to increase dollar reserves
  • [ANALYSIS] Samsung's combined set-making business mimics Apple
  • [Reporter's Notebook] Difficulties ahead for Dayou
  • Australia's conditional approval of COVID-19 treatment unlikely to help Celltrion rebound
DARKROOM
  • La Palma volcano erupts

    La Palma volcano erupts

  • 'Squid Game' spreads over the world

    'Squid Game' spreads over the world

  • Daily life in Haiti after a series of environmental disasters and political unrest

    Daily life in Haiti after a series of environmental disasters and political unrest

  • Daily life in Kabul under Taliban rule

    Daily life in Kabul under Taliban rule

  • Climate crisis is imminent

    Climate crisis is imminent

iscu
KB
The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group